Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer

NCT00024167 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00024167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00024167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2002
Completion date
Not reported
Enrollment
265 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer